Cells were cotransfected with pCK118 and with plasmids encoding for different synthetic promoters pCK123 (P TAL , minimal promoter), pCK121 (P SRE , serum response element), pCK122 (P AP1 , activator protein 1) or pCK53 (P CRE , cAMP-response element) before exposure to 100µM histamine for 24h. Thereafter, SEAP activity was assessed in the supernatant of cells. b) Influence of different constitutive promoters driving HRH2 expression in HEK293 cells. Cells were cotransfected with pCK118 or pCK120 and pCK53, before exposure to 100µM histamine for 24h. Thereafter, SEAP activity was assessed in the supernatant of cells. c) Performance of different mammalian cell lines. BHK21, CHO-K1, HEK293 and HeLa cells were cotransfected with pCK120 and pCK53 before induction with 100µM histamine for 24h. Thereafter, SEAP activity was quantified in culture supernatant. d)
Histamine dose response of pCK120/pCK53-cotransfected HEK293 cells. pCK120/pCK53cotransfected HEK293 cells were exposed the specific histamine concentrations before SEAP activity was assessed in the supernatant of cells. a) Schematic illustration of stably introduced genetic components into HEK293 cells (see plasmid table S1 for details). b) Histamine dose response of the transgenic polyclonal cell line HSD SEAP-polyclonal , which was selected for 3 weeks in DMEM supplemented with 20µg/mL blasticidin. c) Histamine-dependent SEAP expression of 32 monoclonal cell populations (HSD SEAP(n) ). Individual clones derived from HSD SEAP-polyclonal cells were exposed to 100nM histamine after SEAP activity was assessed in supernatant of cells. d) Histamine dose response curves of seven selected monoclonal HSD SEAP(n) cell populations. See Fig. 1d for HSD SEAP32 dose response.
Supplementary Figure 3 | Influence of human serum on HSD SEAP32 cell response.
HSD SEAP32 cells were exposed to different dilutions of human serum in standard cell culture medium. Histamine was added to the mixture to a final concentration of 100nM. After 24h SEAP activity was assessed in the supernatant of cells.
Supplementary Figure 4 | Robustness of HSD SEAP32 cell responses.
Whole blood samples taken from the same donor at three different time points,were exposed to either degranulation buffer alone, 1µg/mL anti-IgE or 1µM fMLF. Serum containing released histamine was directly added onto HSD SEAP32 cells, before SEAP was profiled in the culture supernatant. The mean of at least two histamine release assays per time point ± s.d. is shown.
Supplementary Figure 5 | Illustration of the intra-assay variation of allergy profiles
shown in Figure 3 .
Data of the allergy profiles obtained with HSD SEAP32 cells illustrated in Figure 3 . The mean of at least two different histamine release assay per condition ± s.d. is shown.
Supplementary Figure 6 | Reproducibility of allergy profiles.
The same samples of the histamine release assay obtained for donors B and C shown in Figure 3 were retested after two freeze-thaw cycles using another batch of HSD SEAP32 cells.
SEAP levels were quantified after 24h. Each cell of the heat map represents the mean of at least two histamine release assays. pCMV-SPORT6-based vector containing HRH2 full-length cDNA (SB, cat. no. IRATp970G0878D).
SUPPLEMENTARY
GenBank: BC054510 pCK118 P hCMV -driven HRH2 expression vector (P hCMV -HRH2-pA). HRH2 was PCR-amplified from pHRH2 using oligonucleotides oCK140 (5'-GGAATTCCACCATGGCACCCAATGGCACAGC-3', EcoRI underlined) and oCK141 (5'-GCTCTAGATCATAATTCCTGG-CATGTGGTG-3', XbaI underlined) restricted with EcoRI/XbaI and cloned into corresponding sites (EcoRI/XbaI) of pcDNA3.1(+).
This work pCK120 P -driven HRH2 expression vector (P -HRH2-pA). HRH2 was PCR-amplified from pHRH2 using oligonucleotides oCK140 and oCK141 restricted with EcoRI/XbaI and cloned into corresponding sites (EcoRI/XbaI) of pCK25.
This work pCK121 P SRE -driven SEAP expression vector (P SRE -SEAP-pA). P SRE was excised with NotI/HindIII from pSRE-luc and cloned into corresponding sites (NotI/HindIII) of pSEAP2-basic.
This work pCK122 P AP1 -driven SEAP expression vector (P CRE -SEAP-pA). P AP1 was excised with NotI/HindIII from pAP1-luc and cloned into corresponding sites (NotI/HindIII) of pSEAP2-basic.
This work pCK123 P TAL -driven SEAP expression vector (P CRE -SEAP-pA). P TAL was excised with NotI/HindIII from pTAL-luc and cloned into corresponding sites (NotI/HindIII) of pSEAP2-basic.
This work pDA134 P CREm -driven Citrine expression vector (P CREm -Citrine-pA). Citrine was PCR-amplified from pEV-UAS-H2B-Citrine using oligonucleotides oDA183 (5'-CCGGAATTCCACCATGCCAGAGCCAGCGAAGTC-3', EcoRI underlined) and oDA184 (5'-GACCCGCGCGCTCAATGATGATGATGATGATGG-3', BssHII underlined), partially restricted with EcoRI/BssHII and cloned into corresponding sites (EcoRI/BssHII) of pSP16.
This work
Abbreviations: Citrine, improved version of the yellow fluorescent protein; H2B, histone H2B; HRH2, human histamine receptor H2; Luc, firefly luciferase; MCS, multiple cloning site; mUTS, mammalian urate-dependent transsilencer; PCR, polymerase chain reaction; pA, polyadenylation signal; P UAS , synthetic mammalian promoter containing an upstream activation sequence; P SRE , synthetic mammalian promoter containing a serum response element; P AP1 , synthetic mammalian promoter containing an activator protein 1-response element; P TAL , TATA-like promoter region from herpes simplex virus lacking the enhancer
